Kite first to submit CAR-T therapy in Europe
admin 1st August 2017 Uncategorised 0Kite Pharma has submitted the first CAR-T cell therapy in Europe, seeking permission to market its axicabtagene ciloleucel (axi-cel) to treat patients with three subtypes of aggressive non-Hodgkin lymphoma (NHL).
More: Kite first to submit CAR-T therapy in Europe
Source: News